SecBot SecBot

NEU

NEWMARKET CORP
NYSE· Industrial Organic Chemicals· Inc. VA· CIK 0001282637 Biotech & Drug Discovery
$696.68 −12.51 (−1.76%)
Nov 16 4:00 PM ET · prev $709.19
Market cap
$6.5B
Mid cap
1 year
−6.5%
from $744.76 · Nov 17
30 days
−20.8%
from $879.80
52-week range
$584.66–961.92
−28% from high · low Mar 13
Avg volume 20D
144.6K
shares / day
Short interest
604.4K
≈6.6% of shares · +12.0%
Days to cover
4.8
at average volume
Insider net
+$247.7K
1 buyer · 0 sellers · 12 mo
New fund stakes
1
Q2 2026 13F · 0 exits
Filing reports
6
analyzed by SecBot
SecBot read BEARISH 3 reports · 90 days
Balance 1 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/3

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $247.7K at an average $619.21. No open-market sales. Price is 13% above their cost.

  • InstitutionsMIXED

    Q2 2026: 30 added (1 new), 34 trimmed or exited. Largest new: Jane Street Group $14.9M.

  • Short sellersSTEADY

    Short interest +12.0% to 604.4K shares. 4.8 days to cover, ≈6.6% of shares.

  • TrendDOWNTREND

    18% below its 50-day average.

Who's buying

13F· Q2 2026
1
new positions
0
exits
$14.9M
in new stakes
FundMoveSharesValue
Boston PartnersADD323,902$256.0M
Gotham Asset Management, LLCDOUBLED130,865$103.5M
CAISSE DE DEPOT ET PLACEMENT DU QUEBECTRIM91,650$72.5M
GOLDMAN SACHS GROUP INCADD73,501$58.2M
UBS Group AGTRIM59,120$46.8M
JONES FINANCIAL COMPANIES LLLPADD47,595$37.7M
FIRST TRUST ADVISORS LPADD44,373$35.1M
MILLENNIUM MANAGEMENT LLCTRIM31,763$25.1M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Apr 2019
Recent actions
DateFirmActionRating
Apr 1, 2019Buckingham Research
INITIATE
INITIATEUnderperform
Sep 30, 2016BMO Capital
DOWNGRADE
DOWNGRADEMarket Perform
Jul 29, 2016Longbow Research
DOWNGRADE
DOWNGRADENeutral
Mar 10, 2016Longbow Research
UPGRADE
UPGRADEBuy

Insider ledger

Form 4
$247.7K
bought · 1 insider
$0
sold · 0 insiders
+12.5%
vs their $619.21 cost
DateInsiderTypeValue
Oct 2, 2026
ROGERS JAMES E
Director
Oct 2, 2026
GIFT12 sh
Sep 9, 2026
GOTTWALD BRUCE C
10%+ Owner
Sep 9, 2026
GIFT132 sh
Jul 1, 2026
Xu Ting
Director
Jul 1, 2026
AWARD157 sh
Jul 1, 2026
Harris H Hiter III
Director
Jul 1, 2026
AWARD157 sh
Jul 1, 2026
Ukrop Lowell Simmons
Director
Jul 1, 2026
AWARD157 sh
Jul 1, 2026
ROGERS JAMES E
Director
Jul 1, 2026
AWARD157 sh
Jul 1, 2026
GAMBILL MARK M
Director
Jul 1, 2026
AWARD157 sh
Jun 18, 2026
GOTTWALD THOMAS E
Chairman, President & CEO
Jun 18, 2026
GIFT211 sh

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FYNoneNoneNo data$0.00
Next FYNoneNoneNo data$0.00

Short side

FINRA· Oct 30, 2026
604,359
shares short
+12.0%
vs prior settlement
4.8
days to cover
≈6.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 28, 2026
Earnings result
NEU Q3 2026 Earnings: EPS $13.5
Jul 29, 2026
Earnings date
NEU Q2 2026 Earnings Scheduled, 2026-07-29
Apr 22, 2026
Earnings date
NEU Q1 2026 Earnings Scheduled, 2026-04-22
Apr 14, 2026
Short interest
FTD: NEU, 4,600 shares ($3.0M) failed to deliver
Settlement: 20260414, Price: $659.18, FTD Value: $3,032,228, NEWMARKET COPR (HOLDING COMPAN
Apr 6, 2026
Short interest
FTD: NEU, 3,515 shares ($2.2M) failed to deliver
Settlement: 20260406, Price: $635.86, FTD Value: $2,235,047.9, NEWMARKET COPR (HOLDING COMPAN

SecBot reports

6 filings · 0 bullish · 2 bearish · 4 neutral
All NEU filing & press-release reports (6)